Archive for October, 2007
Treadmill training helps Down syndrome babies walk
Starting Down syndrome infants on treadmill training for just minutes a day can help them walk up to four or five months earlier than with only traditional physical treatment, a new study from the University of Michigan says. The study also suggests that infants who do high intensity treadmill training may walk even sooner……..
Original post by Health news from medicineworld.org
No commentsBrain marker for predicting Alzheimer’s disease
Duke University Medical Center scientists have used imaging technology to identify a new marker that may help identify those at greatest risk for cognitive decline and the development of Alzheimer’s disease. The study focused on people with mild cognitive impairment (MCI), a condition that affects an estimated four to five million individuals in the United States. People with MCI are at increased risk for developing Alzheimer’s disease in the future and approximately 30-50 percent of MCI subjects will develop Alzheimer’s if followed over a three- to five-year period……..
Original post by Health news from medicineworld.org
No commentsChemical that Triggers Parkinson’s Disease
Scientists at the Saint Louis University School of Medicine have discovered the key brain chemical that causes Parkinson’s disease - a breakthrough finding that could pave the way for new, far more effective therapies to treat one of the most common and debilitating neurological disorders. Currently, the main approach for treating Parkinson’s disease, which afflicts more than 1.5 million Americans, is to replace dopamine that’s lost when the cells that produce it die off and cause the disorder. With this new research, however, researchers can better work toward ‘neuroprotective’ therapies - those that actually block dopamine cells from dying off in the first place……..
Original post by Health news from medicineworld.org
No commentsTechnology For Early Detection Of Viruses
Iowa State University scientists have developed a technology that detects a single molecule of the virus linked to cervical cancer in women. That’s a significant improvement over the current test for the human papillomavirus, said Edward Yeung, an Iowa State Distinguished Professor and the Robert Allen Wright Chair in Chemistry who led the research team that developed the new test. The current test, the Nobel Prize-winning polymerase chain reaction technique, requires 10 to 50 virus molecules for detection……..
Original post by Health news from medicineworld.org
No commentsShield Medicare installs Dycem Contamination Control floor coverings.
April 30, 2004 — Shield Medicare, a leading manufacturer of sterile contamination control products and medical devices, has recently installed several large areas of Dycem contamination control floor coverings within its cleanroom facilities in South Wales.
Suzanne Stubbs, Shield Medicare’s Technical Manager said, ” We installed a piece of Dycem in our facility 12 months ago as part of our ongoing programme to control contamination. It was so effective at removing contamination from both feet and wheels that we decided to increase the number of Dycem areas as we built our additional cleanrooms and moved towards more controlled warehouse environments.”
Dycem manufacture a range of contamination control floor coverings and mat solutions, which have been independently tested and proven to prevent over 99% of contamination from entering a critical area. All Dycem products have a high surface energy creating short electro magnetic forces, which attract, collect and retain particulates.
Dycem’s, Alan Fisher, said, “we worked very closely with Shield Medicare to offer the best floor covering solutions for their facilities. The biggest threat to the standards of cleanliness in any facility, is contamination brought in on people’s feet and wheels of trolleys. Here, as in all controlled environments, particles, bacteria, fungi and other contaminants threaten product quality, productivity and company reputation. This problem can only be solved by installing a fully effective contamination control system”.
Shield Medicare is so pleased with the effectiveness of Dycem, that it has installed both Dycem CleanZone and Workzone within its facilities. Cleanzone can be fitted to any length or width, is permanently installed and is a cost effective method of controlling footborne contamination. Workzone, a heavy-duty contamination control floor covering, is specifically designed to remove and retain wheelborne contamination in controlled areas subject to heavy wheeled traffic such as forklifts, pallet trucks, large trolleys and carts.
Dycem is easy to clean and maintain. All you need to do is clean Dycem at the end of a shift or at the end of the day. Dycem products are silicon free, Dop free, non-outgassing and non-particulating. All products are simple to install, and remain effective for up to five years.
Suzanne Stubbs would recommend all companies evaluate Dycem. She said, “I have personally carried out tests which have shown how effective the Dycem is at removing contamination including bacteria, moulds and yeasts. I have also undertaken cleaning studies to demonstrate that all viable and non-viable particles can be easily and completed removed. I would suggest that anyone interested in controlling contamination should evaluate the Dycem material as soon as they can”.
No commentsRavenswood Medical Professional Group, S.C. Selects PLEXIS Healthcare Systems’ Claims Manager after Extensive Search
Ashland, Oregon ? September 24, 2002 ? http://www.plexisweb.com“>PLEXIS Healthcare Systems, Inc. announced today that Ravenswood Medical Professional Group, S.C., located in Chicago, IL, has purchased its core claims processing software, PLEXIS Claims Manager. The PLEXIS’ suite of products offers payers, benefit administrators and health plans the functionality to facilitate accurate and automatic claims adjudication, referral authorizations, benefit administration, and contract management, while meeting all present HIPAA compliance requirements.
Ravenswood Medical Professional Group is a private medical group that has been providing high quality primary care and specialty services to residents on the North Side of Chicago for over 30 years. The organization and its core group of primary care physicians accept managed care risk in a medical group model format, which includes over 100 specialist physicians in a wide variety of outpatient and inpatient locations.
“We have been working steadily to improve our information systems infrastructure in business and clinical operations over the past few years,” said Alan Glick, Administrator at Ravenswood Medical Professional Group. “Moving from a manual to an automated system that could provide comprehensive referral, utilization management, claims, reporting and ERISA compliance functionality was a key initiative for our group. After investigating over 10 systems and completing in-house demonstrations and reference checks on the final candidates, we found that PLEXIS most comprehensively met our functional, technical, cost and organizational strength requirements. We look forward to a successful, long-term relationship with PLEXIS,” Mr. Glick continued.
PLEXIS Healthcare Systems’ CEO and President, Jorge Yant stated, “We are pleased to be an integral part of Ravenswood’s information technology upgrade. They are a very well managed medical group and the extensive search they conducted for a claims processing partner exemplifies this. We also look forward to a long and productive relationship with Ravenswood.”
About PLEXIS Healthcare Systems
PLEXIS Healthcare Systems, Inc., a healthcare technology company based in Ashland, Oregon, has been developing high-end claims processing software for the Windows platform since 1996. PLEXIS Healthcare Systems provides advanced technology tools that enable healthcare organizations to streamline and automate their claims payment and medical case management requirements. For more information, please call toll free (877) 475-3947 or visit http://www.plexisweb.com“>www.plexisweb.com.
Can statins make radiation more effective?
Prostate cancer patients who receive high-dose radiation therapy and also take statin drugs usually used to lower cholesterol have a 10 percent higher chance of being cured of their cancer at 10 years after diagnosis (76 percent), in comparison to those who dont take these medications (66 percent), as per a research studypresented at a scientific session October 31, 2007, at the American Society for Therapeutic Radiology and Oncologys 49th Annual Meeting in Los Angeles……..
Original post by Health news from medicineworld.org
No comments